Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CatSci
CatSci
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
CatSci wins Welsh government SMART Capital Equipment Grant for oligonucleotide development
CatSci has won a Welsh Government SMART Capital Equipment Fund grant to enhance their oligonucleotides capability and offer more and better R&D and manufacturing solutions to customers
Analysis
CatSci expands capabilities to offer expert cGMP analytical development services
CatSci is thrilled to announce the launch of its expert cGMP analytical capabilities in Dagenham, UK
Manufacturing
Catsci welcomes His Majesty’s Lord-Lieutenant in Wales
This special visit was to commemorate CatSci’s monumental achievement in winning The Queen’s Award for Enterprise: International Trade 2022
Manufacturing
CatSci's new partnership with AGC Pharma Chemicals
AGC Pharma Chemicals have more than 40 years of small molecule CDMO and 60 years of API manufacturing experienc
Manufacturing
CatSci invests in oligonucleotides production capability
Oligonucleotides are an emerging modality and an innovative technology offering new therapeutics opportunities to treat previously unmet patients’ needs
Manufacturing
CatSci wins at Bionow Awards
“We are dedicated to continually evolving to support pharmaceutical companies all over the globe and address their CMC demands”
Finance
CatSci opens Dagenham laboratory with analytical focus
The facility has been equipped analytical equipment through a collaboration with Shimadzu Corporation
Subscribe now